Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats
Pharmacological Research2020Vol. 164, pp. 105357–105357
Citations Over TimeTop 10% of 2020 papers
Martina Di Bartolomeo, Tibor Štark, Oriana Maria Maurel, Fabio Arturo Iannotti, Martin Kuchař, Jana Kučerová, Fabiana Piscitelli, Samuele Laudani, Vladimír Pekařík, Salvatore Salomone, Beatrice Arosio, Raphael Mechoulam, Mauro Maccarrone, Filippo Drago, Carsten T. Wotjak, Vincenzo Di Marzo, Matteo Vismara, Bernardo Dell’Osso, Claudio D’Addario, Vincenzo Micale
Related Papers
- → Cannabinoids, endocannabinoids, and cancer(2011)153 cited
- → Ligands for cannabinoid receptors, promising anticancer agents(2016)52 cited
- → Medicinal potential of anandamide as a representative endocannabinoid and its effect at the cellular level in skin(2023)3 cited
- → Role of lipids and lipid signaling in the development of cannabinoid tolerance(2005)20 cited
- → Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) in subcutaneous tissue and fasciae(2015)